0001658551-20-000002.txt : 20200701 0001658551-20-000002.hdr.sgml : 20200701 20200701105705 ACCESSION NUMBER: 0001658551-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200701 DATE AS OF CHANGE: 20200701 EFFECTIVENESS DATE: 20200701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amylyx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001658551 IRS NUMBER: 464600503 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-370064 FILM NUMBER: 201004459 BUSINESS ADDRESS: STREET 1: 43 THORNDIKE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-683-0917 MAIL ADDRESS: STREET 1: 43 THORNDIKE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 D 1 primary_doc.xml X0708 D LIVE 0001658551 Amylyx Pharmaceuticals, Inc. 43 THORNDIKE STREET CAMBRIDGE MA MASSACHUSETTS 02141 617-683-0917 DELAWARE None None Corporation true Joshua Cohen 43 Thorndike Street Cambridge MA MASSACHUSETTS 02141 Executive Officer Director Justin Klee 43 Thorndike Street Cambridge MA MASSACHUSETTS 02141 Executive Officer Director Stephen Chubb 43 Thorndike Street Cambridge MA MASSACHUSETTS 02141 Director George Milne 43 Thorndike Street Cambridge MA MASSACHUSETTS 02141 Director Peter Finn c/o Rubin and Rudman LLP 53 State Street Boston MA MASSACHUSETTS 02110 Executive Officer Walter Gilbert 43 Thorndike Street Cambridge MA MASSACHUSETTS 02141 Director Isaac Cheng 43 Thorndike Street Cambridge MA MASSACHUSETTS 02141 Director Felix Von Coerper 43 Thorndike Street Cambridge MA MASSACHUSETTS 02141 Director Pharmaceuticals Decline to Disclose 06b false 2020-06-18 false true false 10000 30000000 30000000 0 false 17 0 0 0 true Executive Compensation false Amylyx Pharmaceuticals, Inc. PETER B. FINN Peter B. Finn Secretary 2020-07-01